References
- Griffiths W AD. Pityriasis rubra pilaris. Clin Exp Dermatol 1980; 5: 105–12
- Vigliogha P A. Therapeutic evaluation of the oral retinoid RO 10–9359 in several non-psoriatic dermatoses. Br J Dermatol 1980; 103: 483–7
- Lauharanta J, Lassus A. Treatment of pityriasis rubra pilaris with an oral aromatic retinoid (RO 10–9359). Acta Derrn Venereol (Stockh) 1980; 60: 460–2
- Kanerva L, Lauharanta J, Niemi K M, et al. Ultrastructure of pitynasis rubra pilaris with observation during retinoid treatment. Br J Dermatol 1983; 108: 653–63
- Marks R, Finlay A Y, Holt P JA. Severe disorders of keratinization: effects of treatment with Tigason (etret-inate). Br J Dermatol 1981; 104: 667–73
- Borok M, Lowe N. Pityriasis rubra pilaris: further observations of systemic retinoid therapy. J Am Acad Dermatol 1990; 22: 792–5
- Finzi A F, Altomare G, Bergamaschimi L, et al. Pityriasis rubra pilaris and retinol-binding protein. Br J Dermatol 1981; 104: 253–6
- Stoll D M, King L E, Jr, Chytil F. Serum levels of retinol-binding protein in patients with pityriasis. Br J Dermatol 1983; 108: 375, letter
- Soeprono F. Histologic criteria for the diagnosis of pityriasis rubra pilaris. Am J Dermatopathol 1986; 8: 277–83
- Hanke C W, Steck W D. Childhood-onset PRP treated with methotrexate administered intravenously. Cleve Clin Q 1983; 50(2)201–3
- Randle H W, Diaz-Perz J L, Winkelmann J RK. Toxic doses of vitamin A for pityriasis rubra pilaris. Arch Dermatol 1980; 888–92
- Griffiths W AD. Vitamin A and pityriasis rubra pilaris. J Am Acad Dermatol 1982; 7: 555, letter
- Risch J, Ashton R E, Lowe N J, et al. 13-cis-Retinoic acid for dyskeratinizing diseases-clinicopathologic responses. Clin Exp Dermatol 1984; 9: 472–83